Fenwick & West represented Stoke Therapeutics, Inc, an emerging biotechnology company working to increase gene expression to treat a wide array of severe genetic diseases, in its $40 million Series A financing. The Series A round was provided by founding investor Apple Tree Partners.

Stoke will use the funds to support the further advancement of multiple pre-clinical development programs. More information about Stoke’s $40 million Series A financing can be obtained from the company press release.

The Fenwick transaction team was led by corporate lawyers Alan Smith, Ashley Walter and Annie Omata.

Login

Don’t have an account yet?

Register